• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Histidine triad nucleotide-binding protein 3 (HINT3)

ACP11763

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP11763 Target NameHINT3
Target SynonymsHINT-3; HINT3; HINT3_HUMAN; Histidine triad nucleotide-binding protein 3FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range2-182
Protein LengthFull Length of Mature ProteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ9NQE9
Background Information
  • Uniprot Id

    Q9NQE9

  • Target Species

    Human

  • Target Name

    HINT3

  • Target Full Name

    Adenosine 5'-monophosphoramidase HINT3

  • Target Function

    Exhibits adenosine 5'-monophosphoramidase activity, hydrolyzing purine nucleotide phosphoramidates with a single phosphate group such as adenosine 5'monophosphoramidate (AMP-NH2) to yield AMP and NH2. Hydrolyzes lysyl-AMP (AMP-N-epsilon-(N-alpha-acetyl lysine methyl ester)) generated by lysine tRNA ligase. Hydrolyzes 3-indolepropionic acyl-adenylate and fluorogenic purine nucleoside tryptamine phosphoramidates in vitro.

  • Target Subcellular Location

    Cytoplasm. Nucleus. Note=Localized as aggregates in the cytoplasm and the nucleus.

  • Target Protein Families

    HINT family

  • Target Synonyms

    HINT-3; HINT3; HINT3_HUMAN; Histidine triad nucleotide-binding protein 3

Inquire Recombinant Human Histidine triad nucleotide-binding protein 3 (HINT3) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification